
MUTATIONS
#1
Posted 08 July 2016 - 04:55 PM
#2
Posted 08 July 2016 - 08:07 PM
Gleevec 400 mg
PCR 53%, 41%, 1.69%, 5.63% (Mutation test negative) September 2013
Sprycel 100 mg
PCR 1.1%, 0.2%, 0.2%, 0.6%, .09%, .06%, PCRU June 2015, PCRU Sept 2015, PCRU Dec 2015, 0.042% Mar 2016, 0.122% April 2016, 0.19% June 2016, 0.176% July 2016, .052% Sept 2016, .031% Nov 2016
Diagnosed Basel Skin Cancer December 2012, October 2014 (All cancer removed)
Diagnosed Melanoma April 2015 (All cancer removed)
#3
Posted 09 July 2016 - 08:28 AM
There are two main types of mutations discussed in relation to CML treatment. One is a chromosome mutation, and the other is a kinase mutation. Chromosome mutations are found through a BMB, and kinase mutations are found with a blood draw. Chromosome mutations include the Philadelphia Chromosome itself, as well as others such as trisomy 8, monosomy 7 and others. These secondary chromosome mutations do not automatically reduce TKI drug effectiveness, and some may even be caused by the TKI drug itself. Kinase mutations are in the BCR-ABL messenger signals (mRNA) inside the leukemic cells, and they can sometimes prevent or hinder the TKI drug from binding to the BCR-ABL mRNA, which reduces TKI drug effectiveness.
So if your Onc is discussing a BMB, he is looking for a chromosome mutation which might explain a suboptimal response. For those who had a BMB at diagnosis, a BMB at this point would probably not be very useful unless loss of CCyR occurs. A kinase mutation test is more useful, but you are CCyR so it probably will not work anyway.
Most suboptimal drug response is not caused by mutations of any type, but is caused by other issues. Some day I will post about this issue separately. It is a difficult subject area to cover and there are many unknowns, which is why I have not done this yet. The summary is the reasons are "patient specific" and difficult to identify.
#4
Posted 09 July 2016 - 10:52 AM
In addition if it were determined that there was a mutation, different TKI drugs work better on each mutation. So the Onc is looking to see if there is a reason why you are not responding as optimally as he would like and if there is a specific reason why they can focus on it more directly.
#5
Posted 09 July 2016 - 10:59 AM
#6
Posted 09 July 2016 - 11:57 AM
Gleevec 400 mg
PCR 53%, 41%, 1.69%, 5.63% (Mutation test negative) September 2013
Sprycel 100 mg
PCR 1.1%, 0.2%, 0.2%, 0.6%, .09%, .06%, PCRU June 2015, PCRU Sept 2015, PCRU Dec 2015, 0.042% Mar 2016, 0.122% April 2016, 0.19% June 2016, 0.176% July 2016, .052% Sept 2016, .031% Nov 2016
Diagnosed Basel Skin Cancer December 2012, October 2014 (All cancer removed)
Diagnosed Melanoma April 2015 (All cancer removed)
#7
Posted 09 July 2016 - 01:14 PM
For me, the BMB was not a big deal. Both of mine (at diagnosis and at 1 year) were done with a local.
Dx: Sudden severe anemia detected 07/2011, followed by WBC spike. CML Dx 02/2012.
Rx: 03/2012-Gleevec400. Reduced 02/2013 to Gleevec300 due to side effects (low blood counts).
Response: PCR-Und within 7 mo. on G400. Maintained MMR4-MMR4.5 on G300. PCR-Und since 02/2016.
#8
Posted 09 July 2016 - 03:39 PM
Mine wasn't bad at all. They gave me a local and also a mild sedative so I could stay relaxed. My wife also had one and she couldn't do it. They had to put her under anesthesia. I think it varies from person to person. It might vary depending on who does it also. A nurse told me the PA who did mine was the best ever, so there's that.
DX 3/30/2016 WBC 484.2 FISH 95.3
took Hydrea 3/30-4/11
taking Sprycel 100 mg since 4/5
10 day break from Sprycel for platelet count of 12 4/26-5/8
7/07/2016 1.47% (IS)
9/30/16 BMB PCR .1259 switched to new onc
12/30/16 PCR .1569
4/7/17 PCR .0904 MMR
7/14/17 PCR .0520
12/1/17 PCR .0148
#9
Posted 09 July 2016 - 05:21 PM
FISH 92%
BMB 9:22 translocation
1/19/15 began 400 mg gleevec
1/22/15 bcr 37.2 IS
2/6/15 bcr 12.5 IS
3/26/15 bcr 10.3 IS
6/29/15 bcr 7.5 IS
9/24/15 bcr 0.8 IS
1/4/16 bcr 0.3 IS
Started 100 mg dasatinib, mutation analysis negative
4/20/16 bcr 0.03 IS
8/8/16 bcr 0.007 IS
12/6/16 bcr 0.002 IS
Lowered dasatinib to 70 mg
4/10/17 bcr 0.001 IS
Lowered dasatinib to 50 mg
7/5/17 bcr 0.004 IS
8/10/17 bcr 0.001. Stopped TKI in prep for September surgery.
9/10/17 bcr 0.006
10/10/17 bcr 0.088
#10
Posted 09 July 2016 - 08:16 PM
i've had 2 BMBs with local anesthetic. They were uncomfortable, but not barbaric. I prefer not to be sedated.
#11
Posted 10 July 2016 - 12:42 AM
For me it was certainly "barbaric" and I will ask for sedation if I need to do another one.
3/23/2016 Dx PCR 93.4399% IS, FISH 87%
3/30/16 Sprycel 100mg
4/15/2016 liver toxicity and a brief stint on Tasigna 600mg book-ended by drug breaks
6/6/2016 resumed Sprycel at 50 mg increased to 70 one month later followed by 100mg
6/17/2016 FISH Test 2%
8/22/2016 PCR 0.0035% IS
11/7/2016 PCRU
12/29/2016 PCRU
4/5/2017 PCRU
6/28/2017 PCRU
10/26/2017 PCRU
#12
Posted 10 July 2016 - 10:47 AM
The issue is 99% mental. The actual procedure is not painful, although you can feel the person doing the procedure (pressing on the pelvis, etc). The problem occurs when people think too much about what is happening -- same as with dental procedures. That is why I urge people to listen to a personal music device while having the BMB done. It is only a bad experience if the person makes it that way mentally. After the BMB is done and the sedation wears off there can be some pain, but that is a separate issue.
#13
Posted 10 July 2016 - 12:11 PM
Gleevec 400 mg
PCR 53%, 41%, 1.69%, 5.63% (Mutation test negative) September 2013
Sprycel 100 mg
PCR 1.1%, 0.2%, 0.2%, 0.6%, .09%, .06%, PCRU June 2015, PCRU Sept 2015, PCRU Dec 2015, 0.042% Mar 2016, 0.122% April 2016, 0.19% June 2016, 0.176% July 2016, .052% Sept 2016, .031% Nov 2016
Diagnosed Basel Skin Cancer December 2012, October 2014 (All cancer removed)
Diagnosed Melanoma April 2015 (All cancer removed)
#14
Posted 10 July 2016 - 12:37 PM
Agree that there is a momentary feeling of having the marrow sucked out of you. Very odd feeling.
Overall I do not understand why anyone with CML would not have a BMB done at diagnosis. But if not done then, if the patient does not respond optimally, then one should be done at that point. Pain is pain, but a BMB can provide information that cannot ever be obtained any other way. This disease is just too important to avoid something that is so important.
#15
Posted 10 July 2016 - 10:12 PM
#16
Posted 10 July 2016 - 11:01 PM
10/01/2014 100% Diagnosis (WBC 278k, Blasts 6%, Spleen extended 20cm)
Cancer Sucks!
#17
Posted 11 July 2016 - 12:39 AM
CyCR - Aug 2014, Positive for 1 chromosome Sep 2015. PCR: 12.77 in Oct, 2012 to 0.04 (MDA) in Mar, 2016. 4/2016 - 0.126 (Local lab (IS); 05/2016 - 0.195 (local); 6/2016 - 0.07 (MDA); 7/2016 - 0.03 (local) 9/13/2016 - 0.16 (MDA); 9/26/2016 - 0.31 (MDA); 11/2016 - 0.012 (local); 01/2017 - 0.24 (MDA); 04/2017 - 0.09 (MDA); Cytogenetics show der(1:7)(q10;p10)7 chromosome mutation. Repeat of Sep 2015. PCR - 6/2017- 0.035 (local); 10/2017- 0.02 (MDA)
#18
Posted 11 July 2016 - 06:28 AM
Only one was at diagnosis, had the anxiety med and local anesthesia, didn't really notice anything other than pressure. The local anesthesia was more painful. After the anesthesia wears off though your backside can be quite sore for a while, maybe a week. I can still see a small point where they did the procedure. After getting it done, get a cushion to prop up behind your back to keep your local back from touching anything when you sit and you'll be fine.
08/2015 Initial PCR: 66.392%
12/2015 PCR: 1.573%
03/2016 PCR: 0.153%
06/2016 PCR: 0.070%
09/2016 PCR: 0.052%
12/2016 PCR: 0.036%
03/2017 PCR: 0.029%
06/2017 PCR: 0.028%
09/2017 PCR: 0.025%
12/2017 PCR: 0.018%
Taking Imatinib 400 mg
1 user(s) are reading this topic
0 members, 1 guests, 0 anonymous users